| Literature DB >> 31271598 |
Larissa Marina Santana Mendonça de Oliveira1, Ingrid Maria Novais Barros de Carvalho Costa1,2, Danielle Góes da Silva3, José Rodrigo Santos Santos Silva4, José Augusto Soares Barreto-Filho1,5,6, Marcos Antônio Almeida-Santos7, Joselina Luzia Meneses Oliveira1,5, Mirella Dornelas Batalha Moreira Buarque8,9, Diva Aliete Dos Santos Vieira10, Antônio Carlos Sobral Sousa1,5,6.
Abstract
BACKGROUND: Acute coronary syndrome (ACS) is responsible for high rates of hospital admission and readmission, which are associated with increased costs for the patient and the health system, and increased in-hospital mortality rates.Entities:
Year: 2019 PMID: 31271598 PMCID: PMC6684196 DOI: 10.5935/abc.20190104
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Figure 1Flow chart of the occurrence of readmission within one year after the first admission in patients with acute coronary syndrome.
Socioeconomic data, nutritional status, lifestyle habits, and type of health care provided associated with readmission in patients with acute coronary syndrome in Aracaju, Brazil, 2017
| Variable (%) | Readmission | P value | |
|---|---|---|---|
| Yes | No | ||
| 0.1201 | |||
| Female | 49 (25.39%) | 144 (74.61%) | |
| Male | 66 (19.24%) | 277 (80.76%) | |
| 0.0008 | |||
| White | 55 (29.73%) | 130 (70.27%) | |
| Black/pardo | 54 (16.67%) | 270 (83.33%) | |
| 0.0035 | |||
| < 9 years | 44 (16.18%) | 228 (83.82%) | |
| ≥ 9 years | 71 (26.89%) | 193 (73.11%) | |
| 0.0022 | |||
| ≤ 1 salary/person | 12 (12.63%) | 83 (87.37%) | |
| > 1 salary and ≤ 3 salaries/ person | 20 (14.93%) | 114 (85.07%) | |
| > 3 salaries e ≤ 5 salaries/ person | 29 (23.97%) | 92 (76.03%) | |
| > 5 salaries/ person | 53 (29.12%) | 129 (70.88%) | |
| 0.0599 | |||
| Adults | 35 (16.99%) | 171 (83.01%) | |
| Elderly | 80 (24.24%) | 250 (75.76%) | |
| 0.8271 | |||
| Low weight | 6 (18.18%) | 27 (81.82%) | |
| Normal weight | 48 (22.43%) | 166 (77.57%) | |
| Overweight | 60 (20.91%) | 227 (79.09%) | |
| Inadequate | 83 (20.75%) | 317 (79.25%) | 1.0000 |
| Adequate | 27 (21.09%) | 101 (78.91%) | |
| Inactive | 66 (23.08%) | 220 (76.92%) | 0.3828 |
| Active | 49 (19.6%) | 201 (80.4%) | |
| Inactive | 89 (20.37%) | 348 (79.63%) | 0.6298 |
| Active | 11 (16.92%) | 54 (83.08%) | |
| Inactive | 62 (22.55%) | 213 (77.45%) | 0.2203 |
| Active | 36 (17.56%) | 169 (82.44%) | |
| 1.0000 | |||
| Yes | 15 (22.06%) | 53 (77.94%) | |
| No | 100 (21.37%) | 368 (78.63%) | |
| 0.6105 | |||
| Yes | 17 (18.89%) | 73 (81.11%) | |
| No | 98 (21.97%) | 348 (78.03%) | |
| < 0.0001 | |||
| Private | 89 (29.47%) | 213 (70.53%) | |
| Public | 26 (11.11%) | 208 (88.89%) | |
Chi-square test
Clinical conditions associated with readmissions in patients with acute coronary syndrome in Aracaju, Brazil, 2017
| Variable | Readmission | P value | |
|---|---|---|---|
| Yes | No | ||
| Unstable angina | 20 (20.83%) | 76 (79.17%) | 0.0205 |
| NSTEMI | 56 (27.45%) | 148 (72.55%) | |
| STEMI | 39 (16.53%) | 197 (83.47%) | |
| Arterial hypertension | 97 (22.99%) | 325 (77.01%) | 0.1255 |
| Dyslipidemias | 81 (27.93%) | 209 (72.07%) | 0.0001 |
| Diabetes mellitus | 48 (25.81%) | 138 (74.19%) | 0.0933 |
| Previous CAD | 59 (30.73%) | 133 (69.27%) | 0.0001 |
| Congestive heart failure | 39 (31.45%) | 85 (68.55%) | 0.0030 |
| Angina | 66 (25.38%) | 194 (74.62%) | 0.0408 |
| Previous AMI | 58 (30.53%) | 132 (69.47%) | 0.0002 |
| Previous angioplasty | 31 (32.29%) | 65 (67.71%) | 0.0066 |
| Previous myocardial revascularization | 12 (31.58%) | 26 (68.42%) | 0.1700 |
| Previous chronic kidney disease | 18 (51.43%) | 17 (48.57%) | < 0.0001 |
ACS: acute coronary syndrome; NSTEMI: acute myocardial infarction without ST-segment elevation (NSTEMI); STEMI: acute myocardial infarction with ST-segment elevation (STEMI); AMI: acute myocardial infarction; CAD: coronary artery disease; Chi-square test.
Drug therapy associated with readmissions in patients with acute coronary syndrome in Aracaju, Brazil, 2017
| Variable | Readmission | P value | |
|---|---|---|---|
| Yes | No | ||
| Without ASA for 30 days | 3 (15.8%) | 16 (84.2%) | 1.0000 |
| Without antiplatelet agents for 30 days | 9 (30.0%) | 21 (70%) | 0.2111 |
| Without statin for 30 days | 6 (11.5%) | 46 (88.5%) | 0.2037 |
| Without β-blockers for 30 days | 12 (35.3%) | 22 (64.7%) | 0.0507 |
| Without ACEI and/or ARBs for 30 days | 6 (15.0%) | 34 (85.0%) | 0.4259 |
| Without ASA for 180 days | 5 (14.3%) | 30 (85.7%) | 0.4566 |
| Without antiplatelet agents for 180 days | 9 (16.4%) | 46 (83.6%) | 0.5640 |
| Without statin for 180 days | 8 (10.3%) | 70 (89.7%) | 0.0293 |
| Without β-blockers for 180 days | 12 (24.5%) | 37 (75.5%) | 0.6863 |
| Without ACEI and/or ARBs for 180 days | 16 (24.6%) | 49 (75.4%) | 0.5628 |
acetylsalicylic acid (ASA); ACEI: angiotensin-converting enzyme inhibitors; ARBs: angiotensin receptor blockers; chi-square test or Fisher's exact test
Multiple logistic regression of variables in patients with acute coronary syndrome in Aracaju, Brazil, 2017
| Variables | OR (95%CI) | P value |
|---|---|---|
| Male sex | 0.78 (0.45; 1.38) | 0.396 |
| Public health care | 0.46 (0.21; 0.98) | 0.048 |
| Elderly patients | 1.11 (0.63; 1.99) | 0.718 |
| Black/pardo race | 0.58 (0.34; 1.00) | 0.050 |
| Hypertension | 1.72 (0.85; 3.73) | 0.149 |
| Dyslipidemia | 1.69 (0.96; 3.04) | 0.073 |
| Diabetes mellitus | 0.92 (0.53; 1.56) | 0.749 |
| Congestive heart failure | 1.81 (1.01; 3.21) | 0.042 |
| Without statin for 180 days | 0.76 (0.31; 1.70) | 0.526 |
| High school/higher education | 1.56 (0.87; 2.85) | 0.140 |
| Smoking | 1.43 (0.65; 2.99) | 0.356 |
| Alcohol consumption | 1.93 (0.86; 4.22) | 0.102 |
| STEMI | 1.30 (0.67; 2.61) | 0.445 |
| NSTEMI | 0.97 (0.45; 2.13) | 0.943 |
OR: Odds Ratio; STEMI: acute myocardial infarction with ST-segment elevation (STEMI); NSTEMI: acute myocardial infarction without ST-segment elevation (NSTEMI)